Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoshan Dendrobium Zengye Jiedu Formula is a Traditional Chinese Medicine (TCM) preparation developed by the First Affiliated Hospital of Anhui University of Chinese Medicine. It is specifically designed to manage oral mucositis, a common and debilitating side effect in patients undergoing radiotherapy and chemotherapy. The formula's primary active component is *Dendrobium huoshanense* (Huoshan Shihu), an orchid species endemic to the Huoshan region of China, which is traditionally used to nourish "Yin" and clear heat. Pharmacologically, the formula is thought to exert anti-inflammatory and antioxidant effects, promoting the repair of the oral mucosa and improving the quality of life for cancer patients by counteracting treatment-induced dryness and tissue damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huoshan Dendrobium Zengye Jiedu Formula.